Measurement Tool of Chemotherapy Sensitivity in Advanced Ovarian Cancer
- PMID: 32601078
- DOI: 10.1158/1078-0432.CCR-20-1376
Measurement Tool of Chemotherapy Sensitivity in Advanced Ovarian Cancer
Abstract
The modeled Ca125 ELIMination rate constant K (KELIM) can be used as a measure of chemotherapy sensitivity in women with newly diagnosed advanced epithelial ovarian cancer who are being treated with neoadjuvant chemotherapy. This marker may aid in decision-making regarding surgical resection and alternate systemic treatments in this cohort.See related article by You et al., p. 4625.
©2020 American Association for Cancer Research.
Comment on
-
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial.Clin Cancer Res. 2020 Sep 1;26(17):4625-4632. doi: 10.1158/1078-0432.CCR-20-0054. Epub 2020 Mar 24. Clin Cancer Res. 2020. PMID: 32209570 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
